. Structural bioinformatics-based identification of EGFR inhibitor gefitinib as a putative lead compound for BACE. Chem Biol Drug Des. 2014 Jan;83(1):81-8. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.